The Avoca Group® Announces Jeff Kasher as Executive Chair of the Avoca Quality Consortium®
PRINCETON, N.J.--(BUSINESS WIRE)--Jun 6, 2018--The Avoca Group announced today that Dr. Jeff Kasher has assumed the role of Executive Chair for the Avoca Quality Consortium (AQC), its member-based industry collaborative focused on driving efficiency, improving quality, and mitigating risk in clinical trial execution. The AQC is comprised of clinical operations, quality, and outsourcing professionals from over 90 pharma, biotech, CROs, and clinical service providers. As the Executive Chair, Dr. Kasher will guide the strategic direction of AQC initiatives and help The Avoca Group achieve its vision of driving positive industry change through the AQC. Dr. Kasher will serve as a liaison between Member organizations and the AQC to ensure that AQC deliverables exceed expectations and drive innovation and quality in the clinical trial ecosystem.
A pharmaceutical development change expert of nearly 30 years, Dr. Kasher’s expertise includes novel product development from bench through market launch, research and clinical trial leadership, innovation center start-up, as well as new industry paradigm creation. He is passionate about improving outcomes, bringing patients and research sites into the development process, and dramatically decreasing time to market. Dr. Kasher is the former Vice President of Clinical Innovation and Implementation at Eli Lilly, and Founder and President of Patients Can’t Wait.
“I am thrilled to be serving the AQC in this capacity,” Jeff Kasher said. “The AQC and The Avoca Group are providing the Life Sciences industry with innovative solutions and services to improve quality and increase compliance within clinical research. I can think of no better way to take clinical trial execution to the next level than through the ongoing efforts of this consortium.”
The AQC will host its 7 th Annual Global Quality Summit 13-14 June 2018 at the Hotel InterContinental in Dublin, Ireland. Dr. Kasher will facilitate the Keynote discussion and speak alongside Avoca’s Chief Operating Officer, Dennis Salotti, on the future of vendor qualification. The theme for this year’s event – Embrace the Present. Own the Future. – reflects the AQC’s commitment to being at the forefront of the clinical trial industry .
The Summit is supported by Platinum-level sponsor ICON, Gold-level sponsor Purdue Pharma, and Silver-level sponsors Appian Corporation and Longboat Clinical. Additional sponsorship opportunities are available; interested companies can access the Sponsorship Guide for more information. Avoca Quality Consortium Members can contact Caryn Laermer to receive their two complimentary passes. Embrace the Present. Own the Future. Learn more about the Summit at theavocagroup.com/quality-consortium/7th-annual-summit.
About The Avoca Quality Consortium®
The Avoca Quality Consortium (AQC) is a member-based pre-competitive collaborative comprised of clinical operations, quality, and outsourcing professionals from pharma, biotech, CROs, and clinical service providers. The AQC was founded based on a commitment to have a positive impact on clinical trial execution. Each Member organization receives company-wide access to a comprehensive and proprietary Knowledge Center of over 400 leading practices, guidelines, tools, templates, and process documents, as well as AQC research and archived webinars. Learn more about the Consortium here.
About The Avoca Group®
The Avoca Group is an integrated research and consulting firm providing survey research, consulting services, and training in the areas of clinical trial outsourcing, strategic alliances and quality management. Sponsors of clinical research and clinical research organizations have benefited from quantitative and qualitative perception data gathered by The Avoca Group from sites about their reciprocal working relationships. The company’s focus is to help solve complex clinical trial challenges and to improve the quality and efficiency of clinical trial execution. The Avoca Group’s tools include the Diligent® Qualification Platform for vendor qualification and oversight and the eLuminate™ Online Learning Platform to provide consolidated, consistent, and self-paced learning opportunities. Founded in 1999, the company works exclusively in the healthcare industry and has a focus on clinical research and clinical outsourcing. Learn more about The Avoca Group at www.theavocagroup.com and on LinkedIn and Twitter.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180606005399/en/
CONTACT: Crossroads B2B Consulting For The Avoca Group
Laura Vepraskas, 919-523-4402
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL PROFESSIONAL SERVICES CONSULTING RESEARCH SCIENCE
SOURCE: The Avoca Group
Copyright Business Wire 2018.
PUB: 06/06/2018 09:00 AM/DISC: 06/06/2018 09:01 AM